# Dick de Zeeuw

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dick-de-zeeuw/

## Facts

| Field | Value |
| --- | --- |
| Citations | 100,073 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 118 |
| i10-index | 596 |
| Last Known Institution | University Medical Center Groningen |
| OpenAlex ID | https://openalex.org/A5045497276 |
| ORCID iD | 0000-0003-3434-7777 |
| Works | 1,068 |

## Researcher papers

Showing 12 of 35.

- [K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification](https://scholariq.org/papers/k-doqi-clinical-practice-guidelines-for-chronic-kidney-disease-evaluation/)
- [Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-events-in-type-2-diabetes/)
- [Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/effects-of-losartan-on-renal-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)](https://scholariq.org/papers/definition-and-classification-of-chronic-kidney-disease-a-position-statement/)
- [K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease](https://scholariq.org/papers/k-doqi-clinical-practice-guidelines-for-bone-metabolism-and-disease-in-chronic/)
- [The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial](https://scholariq.org/papers/the-effects-of-lowering-ldl-cholesterol-with-simvastatin-plus-ezetimibe-in/)
- [A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/a-trial-of-darbepoetin-alfa-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population](https://scholariq.org/papers/urinary-albumin-excretion-predicts-cardiovascular-and-noncardiovascular/)
- [Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes](https://scholariq.org/papers/cardiorenal-end-points-in-a-trial-of-aliskiren-for-type-2-diabetes/)
- [Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis](https://scholariq.org/papers/progression-of-chronic-kidney-disease-the-role-of-blood-pressure-control/)
- [Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure](https://scholariq.org/papers/renal-function-neurohormonal-activation-and-survival-in-patients-with-chronic/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [University Medical Center Groningen](https://scholariq.org/institutions/university-medical-center-groningen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.